Navigation Links
MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment
Date:1/5/2012

TUCSON, Ariz. and PROVIDENCE, R.I., Jan. 5, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) today announced it has awarded $1.0 million to Tivorsan Pharmaceuticals to help speed pre-clinical work vital to a filing of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a recombinant humanized form of biglycan as a potential muscular dystrophy treatment.  The new funding to the Providence-based biotechnology firm comes from MDA Venture Philanthropy (MVP), a part of MDA's translational research program.

The project being advanced by Tivorsan is focused on treating Duchenne muscular dystrophy (DMD) by up-regulating the utrophin protein that's been shown to provide some compensation for disease-causing dystrophin deficiency in animals with DMD-like muscular dystrophy.  The company's TVN-102 experimental drug is based on biglycan, a naturally occurring protein found on the membrane surrounding each muscle fiber.  In the standard mouse model of DMD, biglycan reduced muscle damage, reduced muscle degeneration and improved muscle function.

DMD is one of nine types of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles.  Caused by mutations in the gene that makes dystrophin, a protein that normally protects muscle cells and keeps them intact, DMD eventually weakens all voluntary muscles, and the heart and breathing muscles.  DMD affects 1 in 3,500 boys with an estimated patient population exceeding 50,000 worldwide.   

"We are delighted to have a productive collaboration with Dr. Justin Fallon's laboratory at Brown University to bring such a promising potential muscular dystrophy treatment to market," said Joel B. Braunste
'/>"/>

SOURCE Muscular Dystrophy Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions)
2. Span Diagnostics Ltd. Hits Bulls eye at ET NOW-IndiaMART Leaders of Tomorrow Awards 2011
3. MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy
4. Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company"
5. WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards
6. GHX Calls on Member Community to Nominate Healthcares Most Impactful Business Partners for GHXcellence Awards
7. The Food and Drug Law Institute to Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf
8. BRAVE Awards Recipients Announced
9. Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products
10. Occupy Oakland Business Fraud Verdict: Oakland Jury Awards $9 Million Against Multi-National Corporation for Business Fraud and Breach of Contract
11. Glenmark Wins Two Prestigious Global Recognitions at SCRIP Awards 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Utah , July 10, 2014  BC Technical, ... and MiE America , Inc., a leading provider ... entered into a long-term agreement naming BC Technical as ... US. MiE and BC Technical announced ... agreement to establish BC Technical as the service and ...
(Date:7/10/2014)... Mass. , July 10, 2014  Decision ... of surveyed infectious disease (ID) specialists are willing ... Company,s Orbactiv (oritavancin) for use as OPAT, approximately ... prescribe these agents to their hospital inpatients. However, ... of OPAT patients are initiated on OPAT following ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... Inc. (Nasdaq: ANTH ), today announced financial results ... Financial Results: Total operating ... $18.7 million, as compared to $6.5 million for the same ... quarter of 2011 were driven by expenses related to site ...
... STAAR Surgical Company (NASDAQ: STAA ), ... ophthalmic products, today reported financial results for the first ... increased 8% to $14.8 million over the first quarter ... (IOL and ICL) sales.  The Company achieved its first ...
Cached Medicine Technology:Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 2STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 3STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 4STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 6STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 7STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 8STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 9STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 10STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 11
(Date:7/13/2014)... July 14, 2014 MED-Ed Facilities is ... our next conference, April 7+8 in Boston at the ... at the recent event. Presentations by individuals or teams ... To review the types of sessions that were presented ... Submit your proposal today! , Conference Director, The ...
(Date:7/13/2014)... 2014 MillionaireCasket.com is a professional supplier of ... wood caskets are selling well in the global market. Recently, ... caskets and launched a special offer for all the ... all the company’s cherry caskets are made with superb materials. ... for people to show respect to the departed saint. MillionaireCasket.com ...
(Date:7/13/2014)... York (PRWEB) July 13, 2014 Intraocular ... Trends and Forecast 2013 - 2019 , Intraocular lens ... suffering from myopia or cataracts. The lenses are inserted ... the cataract surgery intraocular lens replaces the focusing power ... with original crystalline lens to deliver the light focusing ...
(Date:7/13/2014)... July 13, 2014 Victorian Hotel has ... promoting the rental of bikes for its "Cycle the ... Victorian Hotel to tour the area using a rental ... Bicycle enthusiasts love to call Vancouver home, as it ... cycle travel and picturesque journeys through the countryside. Vancouver ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
Breaking Medicine News(10 mins):Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4
... repair damage with natural tissue , THURSDAY, Feb. 4 ... cartilage growth in joints has been developed by U.S. ... joint and stimulates bone marrow stem cells to produce ... No current therapy can do this, according to the ...
... typical 30-hour shifts need to be cut to 16 to ... In November 2000, Helen Haskell took her 15-year-old son to ... Four days later, he was dead. The cause: failure to ... to recognize and act upon declines in patients." , He ...
... , GAINESVILLE, Fla. , Feb. 4 ... announce today that they have jointly selected Sg2 , a healthcare ... children,s hospital. The assessment began in January with findings projected to be ... at Sg2 will handle this very important assessment, delivering the ...
... , , TORRANCE, ... the largest privately held insurance brokerage and consulting firm in ... providers of integrated disease management and wellness programs.  Nurtur and ... program providers, adding an important dimension to the company,s extensive ...
... , , NEW YORK , ... Parkinson,s Research today announced more than $2.8 million ... of biomarkers of PD. The development of biomarkers is of ... therapeutic development, allowing scientists and clinicians to more accurately identify ...
... , Feb 4 Smart Balance, Inc. (Nasdaq: SMBL ... February 25, 2010 , at 9:30 a.m. ET to ... 8:30 a.m. ET the same day.  The webcast will be in ... by dialing 1-800-895-0198 from the United States or 1-785-424-1053 from ...
Cached Medicine News:Health News:Nanofiber Gel May Spur Growth of New Knee Cartilage 2Health News:Campaign Calls for Limits on Doctors' Hours 2Health News:Campaign Calls for Limits on Doctors' Hours 3Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 2Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 3Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 2Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 3Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 4Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 2Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 3Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 4Health News:Smart Balance to Host Webcast/Conference Call on 2009 Fourth-Quarter Results 2
... The MEL 80 is a top quality ... the correction of vision defects even safer, ... of this ultramodern work platform are oriented ... and the rapid recovery of vision. Key ...
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
... be mounted at the patient's bedside, on ... The design retains many of the proven ... the pump drive motor circuits, flow estimator, ... system. Retaining these subsystems maintains compatibility ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: